Abstract
A New Deal for Global Health R&D? The Recommendations of the Consultative Expert Working Group on Research and Development (CEWG)
Highlights
There have been many positive efforts to tackle these issues, including the establishment of diverse public–private product development partnerships (PDPs) like the Medicines for Malaria Venture and Drugs for Neglected Diseases initiative
We propose new strategies for how research in this area can be conducted and a new paradigm for how financial contributions should be determined based on the concept that both the costs and benefits of research and development (R&D) should be shared
We recommend a role for World Health Organization (WHO) in the stronger coordination of R&D and suggest pooling of financial investments to secure efficient allocations to where demands and opportunities are identified through active participation of developing countries
Summary
There have been many positive efforts to tackle these issues, including the establishment of diverse public–private product development partnerships (PDPs) like the Medicines for Malaria Venture and Drugs for Neglected Diseases initiative. Acting upon the CEWG recommendations would constitute a transformative change rather than an incremental improvement. We do call for more money— this is not new in global health, but even more importantly we call for money that is used in smarter ways.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
